Pliant is advancing drug development programs targeting a range of fibrotic diseases, with a focus on fibrotic tissue-specific inhibition of integrins and the TGF-β pathway.

Pharmaceutical

Pliant Therapeutics

Pliant Therapeutics' headquarters in Redwood City, CA, United States

Bernard Coulie

Johanna Colvin Riesen

Ken Imamura

Daniel Park

Chris N. Barnes

Jenny Amaya Amaya

Keithryn Nicolas

Senior Clinical Research Associate

Senior Director, Medical Writer

Director, Early-stage Clinical Development

Director, Clinical Pharmacology

Associate Director, Statistical Programming

Mamta Thakker

Mengqi Zhang

Muyu Su

Davis Chen

Martin Decaris

Andrew You

Lily Cheung

Delphine Imbert

Senior Director, Vendor Outsourcing

Director, Vendor Outsourcing

Diane Ireland

Minnie Kuo

Tim Machajewski

Monica Sandberg

Fernando Rock

Christopher Keenan

Hans Hull

Keith Cummings

Bill DeGrado

Bertus Eksteen

Hal Chapman

Rik Derynck

Bill Greenlee

Naftali Kaminski

Brian Metcalf

Paul Noble

Dean Sheppard

Gayle Crowell

John Curnutte

David Pyott

Hoyoung Huh

Darren Cline

Thomas McCourt

David Phillips

Katharine Knobil

Suzanne Bruhn

The Research and Development Team at Pliant Therapeutics is dedicated to advancing the company's drug development programs targeting fibrotic diseases. This team engages in the discovery, design, and optimization of novel therapies with a focus on fibrotic tissue-specific inhibition of integrins and the TGF-β pathway. Members collaborate closely to conduct experimental research, develop clinical candidates, and transition promising compounds from preclinical studies to clinical trials.

Research and Development Team

The Corporate Board at Pliant Therapeutics provides strategic oversight and governance, ensuring alignment with the company's mission to advance drug development for fibrotic diseases. They make high-level decisions on corporate policies, financial planning, and regulatory compliance, while guiding long-term growth and sustainability.

Corporate Board

The Clinical Development and Operations Team at Pliant Therapeutics is responsible for designing, managing, and executing clinical trials to advance the company’s drug development programs targeting fibrotic diseases. They oversee all aspects of clinical development, including protocol design, regulatory compliance, clinical supply chain management, and trial logistics, ensuring efficient and effective progression from early-stage trials through to late-stage development.

Clinical Development and Operations Team

This department oversees clinical development, operations, and medical affairs to ensure the efficacy and safety of medical products.

Clinical Management

This department oversees quality assurance processes and ensures compliance with regulatory standards across products and services.

Quality Assurance and Compliance

This department conducts scientific research and innovation to develop new products and solutions.

Research and Development

Pliant Therapeutics

Org chart

Board & advisors

Teams

Research and Development Team

Corporate Board

Clinical Development and Operations Team

Clinical Management

Quality Assurance and Compliance

Research and Development

Offices

Pliant Therapeutics

Org chart

Board & advisors

Teams

Research and Development Team

Corporate Board

Clinical Development and Operations Team

Clinical Management

Quality Assurance and Compliance

Research and Development

Offices

Related companies